Evidence map›Paper›PMID 24146809›Full record

ArticlePloS one2013

Targeted gene deletion of miRNAs in mice by TALEN system.

Shuji Takada, Tempei Sato, Yoshiaki Ito, Satoshi Yamashita, Tomoko Kato, Miyuri Kawasumi, Masami Kanai-Azuma, Arisa Igarashi, Tomomi Kato, Moe Tamano and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. The Development of TALE Nucleases for Biotechnology.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Shuji TakadaDepartment of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo, Japan.
Tempei Sato
Yoshiaki Ito
Satoshi Yamashita
Tomoko Kato
Miyuri Kawasumi
Masami Kanai-Azuma
Arisa Igarashi
Tomomi Kato
Moe Tamano
Hiroshi Asahara
National Center For Child Health and Development · JPTokyo Medical and Dental University · JPJapan Science and Technology Agency · JP

Funding

Transcriptional Regulation of ChondrogenesisR01AR050631 · NIAMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ASAHARA, HIROSHI · 2004 to 2021
$5.8M
The role of microRNAs in chondrogenesis and arthritisR56AR050631 · NIAMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ASAHARA, HIROSHI · 2009 to 2009
$475k
NIAMS NIH HHS AR050631NIAMS NIH HHS R01 AR050631NIAMS NIH HHS R56 AR050631
6 · The paper itself

Abstract

Mice are among the most valuable model animal species with an enormous amount of heritage in genetic modification studies. However, targeting genes in mice is sometimes difficult, especially for small genes, such as microRNAs (miRNAs) and targeting genes in repeat sequences. Here we optimized the application of TALEN system for mice and successfully obtained gene targeting technique in mice for intergenic region and series of microRNAs. Microinjection of synthesized RNA of TALEN targeting each gene in one cell stage of embryo was carried out and injected oocytes were transferred into pseudopregnant ICR female mice, producing a high success rate of the targeted deletion of miRNA genes. In our condition, TALEN RNA without poly(A) tail worked better than that of with poly(A) tail. This mutated allele in miRNA was transmitted to the next generation, suggesting the successful germ line transmission of this targeting method. Consistent with our notion of miRNAs maturation mechanism, in homozygous mutant mice of miR-10a, the non- mutated strand of miRNAs expression was completely diminished. This method will lead us to expand and accelerate our genetic research using mice in a high throughput way.

Indexed as

Gene DeletionAnimalsBase SequenceDeoxyribonucleases, Type II Site-SpecificDNA-Binding ProteinsDNA, IntergenicEmbryo, MammalianFemaleGene TargetingGenetic EngineeringMiceMice, Inbred ICRMicroinjectionsMicroRNAsMolecular Sequence DataOocytesDeoxyribonucleases, Type II Site-SpecificDNA-Binding ProteinsDNA, Intergenicendodeoxyribonuclease FokIMicroRNAsMIRN10 microRNA, mouseRecombinant Fusion Proteins

Identifiers

PMID24146809
PMCPMC3797721
OpenAlexW2098270492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.